These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8109944)

  • 41. Antibiotic susceptibility of alpha- and nonhemolytic streptococci from patients and healthy adults to 24 antimicrobial drugs.
    Traub WH; Leonhard B
    Chemotherapy; 1997; 43(2):123-31. PubMed ID: 9084921
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro antimicrobial susceptibilities of Yersinia enterocolitica and related species isolated from slaughtered pigs and pork products.
    Kwaga J; Iversen JO
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2423-5. PubMed ID: 2088198
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Natural Antimicrobial Subtilosin A Synergizes with Lauramide Arginine Ethyl Ester (LAE), ε-Poly-L-lysine (Polylysine), Clindamycin Phosphate and Metronidazole, Against the Vaginal Pathogen Gardnerella vaginalis.
    Cavera VL; Volski A; Chikindas ML
    Probiotics Antimicrob Proteins; 2015 Jun; 7(2):164-71. PubMed ID: 25588687
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro susceptibilities of Campylobacter-like organisms to twenty antimicrobial agents.
    Flores BM; Fennell CL; Holmes KK; Stamm WE
    Antimicrob Agents Chemother; 1985 Aug; 28(2):188-91. PubMed ID: 3834828
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro susceptibilities of aerotolerant Campylobacter isolates to 22 antimicrobial agents.
    Kiehlbauch JA; Baker CN; Wachsmuth IK
    Antimicrob Agents Chemother; 1992 Apr; 36(4):717-22. PubMed ID: 1503434
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro activity of ciprofloxacin and norfloxacin against Gardnerella vaginalis.
    Machka K
    Eur J Clin Microbiol; 1984 Aug; 3(4):374. PubMed ID: 6237906
    [No Abstract]   [Full Text] [Related]  

  • 47. [In vitro antimicrobial synergy against imipenem-resistant Acinetobacter baumannii].
    Sung H; Choi SJ; Yoo S; Kim MN
    Korean J Lab Med; 2007 Apr; 27(2):111-7. PubMed ID: 18094561
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antimicrobial susceptibilities and serogroups of clinical strains of Clostridium difficile isolated in France in 1991 and 1997.
    Barbut F; Decré D; Burghoffer B; Lesage D; Delisle F; Lalande V; Delmée M; Avesani V; Sano N; Coudert C; Petit JC
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2607-11. PubMed ID: 10543736
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Susceptibility of Clostridium perfringens type A to 23 antimicrobial drugs.
    Traub WH; Karthein J; Spohr M
    Chemotherapy; 1986; 32(5):439-45. PubMed ID: 2875853
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative susceptibilities of ampicillin and chloramphenicol resistant Haemophilus influenzae to fifteen antibiotics.
    Campos J; Garcia-Tornel S
    J Antimicrob Chemother; 1987 Mar; 19(3):297-301. PubMed ID: 3494722
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of the Etest with agar dilution for antimicrobial susceptibility testing of Haemophilus ducreyi.
    Lagergård T; Frisk A; Trollfors B
    J Antimicrob Chemother; 1996 Nov; 38(5):849-52. PubMed ID: 8961054
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antimicrobial susceptibility of anaerobic bacteria in Australia.
    Chen SC; Gottlieb T; Palmer JM; Morris G; Gilbert GL
    J Antimicrob Chemother; 1992 Dec; 30(6):811-20. PubMed ID: 1289355
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Susceptibility of Campylobacter fetus to twenty-two antimicrobial agents.
    Chow AW; Patten V; Bednorz D
    Antimicrob Agents Chemother; 1978 Mar; 13(3):416-8. PubMed ID: 263884
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The comparative in-vitro activity of pefloxacin.
    King A; Phillips I
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():1-10. PubMed ID: 2940213
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lysozyme as a cotreatment during antibiotics use against vaginal infections: An in vitro study on Gardnerella vaginalis biofilm models.
    Thellin O; Zorzi W; Zorzi D; Delvenne P; Heinen E; ElMoualij B; Quatresooz P
    Int Microbiol; 2016 Jun; 19(2):101-107. PubMed ID: 27845497
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro susceptibility of Clostridium difficile isolates to 12 antimicrobial agents.
    Gianfrilli P; Luzzi I; Pantosti A; Occhionero M
    Chemioterapia; 1984 Feb; 3(1):41-4. PubMed ID: 6535652
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics of metronidazole and its principal metabolites and their activity against Gardnerella vaginalis.
    Easmon CS; Ison CA; Kaye CM; Timewell RM; Dawson SG
    Br J Vener Dis; 1982 Aug; 58(4):246-9. PubMed ID: 6980684
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of the E test for antimicrobial susceptibility testing of Porphyromonas gingivalis.
    Pajukanta R; Asikainen S; Forsblom B; Piekkola M; Jousimies-Somer H
    Oral Microbiol Immunol; 1994 Apr; 9(2):123-5. PubMed ID: 8008429
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence of erythromycin and clindamycin resistance among Streptococcus agalactiae isolates in Germany.
    Schoening TE; Wagner J; Arvand M
    Clin Microbiol Infect; 2005 Jul; 11(7):579-82. PubMed ID: 15966978
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Susceptibility of clinical isolates of Campylobacter jejuni to twenty-five antimicrobial agents.
    Lariviere LA; Gaudreau CL; Turgeon FF
    J Antimicrob Chemother; 1986 Dec; 18(6):681-5. PubMed ID: 3493235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.